Skip to content

Colleen Jonsson

  • PhD
  • Professor and Director
  • University of Tennessee Health Science Center
  • 31h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 2951CitationsNumber of citations received by Colleen's publications. Updated daily.

Recent publications

  • A Discrete-Time Rodent-Hantavirus Model Structured by Infection and Developmental Stages SI Deterministic Model Description of Model

    • Wesley C
    • Allen L
    • Jonsson C
    • et al.
  • Hantaan Virus

    • Jonsson C
    • Chu Y
    • Ontiveros S

Professional experience

Professor and Director

University of Tennessee Health Science Center

July 2017 - Present


Postdoctoral Fellow

University of Medicine and Dentistry of New Jersey-Piscataway

August 1990 - August 1993(3 years)


Purdue University

August 1985 - August 1990(5 years)


Dr. Jonsson is a Van Vleet Chair of Excellence in Virology, and Director, Regional Biocontainment Laboratory at the University of Tennessee Health Science Center in Memphis. She has over 20 years of experience in basic and translational research of highly pathogenic human viruses represented in more than 108 publications and 5 patents. Her research on hantaviruses began shortly after the 1993 outbreak in the southwestern region of the USA as a new Assistant Professor at New Mexico State University. Hantaviruses provide an exceptional model system for the study of RNA virus spillover as they constitute a significant source of outbreaks, zoonotic infections and human disease. Her current research focuses on defining the mechanisms that promote maintenance and emergence of hantavirus within its rodent reservoir in nature in field studies in the InterAtlantic Forest in Paraguay in collaboration with Dr. Robert Owen. These field studies suggest that hantaviruses spill over into other species of rodents and her research program is focused on the defining the host restrictions that hantaviruses must overcome to adapt to a new, nonreservoir hosts. The study of the emergence and adaption of hantaviruses can provide critical data for models for prediction of RNA viral emergence and mitigation and identification of hantaviral and host targets for therapeutic intervention. She has also devoted much of her career to the discovery of antivirals for RNA viruses such as influenza viruses, SARS CoV, hantaviruses, and more recently, alphaviruses. Her translational efforts have included numerous collaborations in drug discovery with academic, government and biotechnology partners. Internationally, she has led five workshops in Latin America to train small groups in Public Health or research laboratories in recombinant DNA technology, diagnostics, collection of rodent and general biosafety concerning hantavirus. Her research has been funded by the NIH, NSF, ASM, AMFaR and DoD.

Co-authors (365)

  • Gilberto Sabino-Santos Jr
  • François Ferron
  • Ulas Bagci